Gender-Reflective Framing and HPV Vaccine Intentions

How to cite

Böhme, Fabian; Tauchmann, Harald; Yurkevich, Elena. 2026. "Gender-Reflective Framing and HPV Vaccine Intentions." AEA RCT Registry. AEARCTR-0018250. https://doi.org/10.1257/rct.18250-2.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Fabian Böhme* , Harald Tauchmann , Elena Yurkevich

* Primary investigator

Registry ID
AEARCTR-0018250
DOI
https://doi.org/10.1257/rct.18250-2.0
First registered
Last updated
Status
Completed
Trial dates
2026-04-13 – 2026-06-27
Countries
Germany ()
JEL codes
I12, I18, D83, C93
Registry record
http://www.socialscienceregistry.org/trials/18250

Abstract

We evaluate the effectiveness of gender-reflective framing in health communication aimed at increasing HPV vaccination intentions. The human papillomavirus (HPV) causes several cancers in both women and men, yet vaccination coverage in Germany remains below the WHO
target and exhibits a pronounced gender gap. Gender-reflective framing emphasizes protection of a specific gender group and may activate identity-based or empathetic motivations in parental decision-making regarding the vaccination of their children. To test this mechanism,
we conduct a randomized 2 × 2 × 2 factorial online survey experiment with German parents (target N ≈ 2,160). The treatment varies whether the informational message emphasizes cervical cancer (female frame) or penile cancer (male frame), while the parent’s gender and the focal child’s gender provide the remaining two factors. The primary outcome is parents’ intention to vaccinate their child against HPV (0–10 scale).

Intervention

Parents of children under age 9 in Germany read a short informational message about HPV vaccination. The message emphasizes either female-specific cancers (cervical cancer) or male-specific cancers (penile cancer).

Experimental design

2 × 2 × 2 between-subject factorial design. Factor 1 (randomized): message emphasis (female-specific vs. male-specific HPV cancers). Factor 2 (observed): parent gender (mother vs. father). Factor 3 (observed): oldest child's gender (daughter vs. son). Target population: parents in Germany whose oldest child is under 9 years of age. Target sample: N ≈ 2,160 (≈270 per cell). Six pre-specified two-sided hypotheses tested on the primary outcome.

Design details

Randomization method
Computer-based individual-level randomization via the Tivian (EFS) survey platform's quota system, stratified by parent gender × child gender (1:1 within each subgroup).
Randomization unit
Individual respondent (no clustering).
Clusters
2,160 individuals (not clustered; same as number of observations).
Observations
2,160 respondents (8 cells × ~270 each).
Arms
~1,080 per message condition. Within each of the four parent–child subgroups (mother-daughter, mother-son, father-daughter, father-son), ~270 receive the female-specific and ~270 the male-specific emphasis.
Primary outcomes
Vaccination intention (0–10 scale): How likely the parent would be to vaccinate their oldest child against HPV once the child reaches the recommended age.
Secondary outcomes
(1) Intention to discuss HPV vaccination at the next pediatric visit (0–10 scale). (2) Binary opt-in for additional HPV vaccination information. (3) Video watch behavior and duration (conditional on opt-in).

Cited by

No citation data available for this registration yet.

Keywords